Tag: FDA-, LOSS

SCFIs account for about 0.54 percent of all ambulatory visits, with trend in annual SCFIs increasing

Estimated prevalence rates ranged from 22 percent for one to 14.8 percent for four or more

Intervention with use of sit-stand desk reduces sedentary behavior but does not reduce BP or pulse wave velocity

Worst trend seen among younger rural adults, while improvements seen in older adults in all areas

59 percent of adults aged 30 years and older with diabetes did not receive treatment in 2022, up 3.5 times from 1990

Substantial burden seen in terms of hospitalizations, ICU admissions, in-hospital deaths, especially in those aged 75 years and older

Palliative care consultations have no significant impact on the likelihood of documented treatment

Spreading misinformation to the community is least common reason for medical board discipline of physicians

Individuals with history of concussion have increased risk for mental illness in the 14 years after delivery

Supplementation with cholecalciferol during pregnancy linked to increased bone mineral content, bone mineral density, lean mass in offspring

Significant reduction seen in VTE rates, with similar reductions for patients with and without obesity

Findings based on wearable-collected, real-world data, independent of clinical and genetic risk factors

Most common adverse events related to surgical procedures, adverse drug events, health care-associated infections

Increased risk for developing any dyslipidemia seen during 2020 to 2022

Fasting shows benefits compared with eating meals or snacks at night